Global Vaccine Market Size & Outlook, 2026-2033

The global vaccine market size was estimated at USD 72,749.4 million in 2025 and is projected to reach USD 115,768.1 million by 2033, growing at a CAGR of 5.8% from 2026 to 2033.
Revenue, 2025 (US$M)
$72,749.4
Forecast, 2033 (US$M)
$115,768.1
CAGR, 2026 - 2033
5.8%
Report Coverage
Worldwide

Global vaccine market highlights

  • The global vaccine market generated a revenue of USD 72,749.4 million in 2025 and is expected to reach USD 115,768.1 million by 2033.
  • The market is expected to grow at a CAGR (2026 - 2033) of 5.8% by 2033.
  • In terms of segment, viral vaccines accounted for a revenue of USD 47,277.7 million in 2025.
  • Other Indication is the most lucrative indication segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2025.
  • Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.

Global data book summary

Market revenue in 2025USD 72,749.4 million
Market revenue in 2033USD 115,768.1 million
Growth rate5.8% (CAGR from 2026 to 2033)
Largest segmentViral vaccines
Fastest growing segmentOther Indication
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationViral Vaccines, Bacterial Vaccines, Cancer Vaccines, Allergy Vaccines, Other Indication

Other key industry trends

  • In terms of revenue, the North America accounted for 40.0% of the global vaccine market in 2025.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
  • By country, Mexico is the fastest growing regional market and is projected to reach USD 1,301.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Vaccine Market Scope

Vaccine market segmentation & scope

Vaccine Market Companies

Name Profile # Employees HQ Website
Moderna Inc View profile 5600 200 Technology Square, Cambridge, MA, United States, 02139 https://www.modernatx.com
BioNTech SE ADR View profile 6133 An der Goldgrube 12, Mainz, RP, Germany, D-55131 https://www.biontech.de
CSL Ltd View profile 32000 655 Elizabeth Street, Melbourne, VIC, Australia, 3000 https://www.csl.com
Sinovac Biotech Ltd View profile 3261 No.39, Shangdi Xi Road, Haidan District, Beijing, China, People's Republic of, 100085 http://www.sinovac.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Serum Institute of India Pvt. Ltd. View profile 1001-5000 Pune, Maharashtra, India, Asia http://www.seruminstitute.com/
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com

Global vaccine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine market will help companies and investors design strategic landscapes.


Viral vaccines was the largest segment with a revenue share of 64.99% in 2025. Horizon Databook has segmented the Global vaccine market based on viral vaccines, bacterial vaccines, cancer vaccines, allergy vaccines, other indication covering the revenue growth of each sub-segment from 2021 to 2033.


  • Global Vaccine Indication Outlook (Revenue, USD Million, 2021-2033)
    • Viral Vaccines
      • Hepatitis
        • Pediatric (Children) Hepatitis
        • Adult Hepatitis
      • Influenza
        • Pediatric (Children) Influenza
        • Adult Influenza
      • HPV
        • Pediatric (Children) HPV
        • Adult HPV
      • MMR
        • Pediatric (Children) MMR
        • Adult MMR
      • Rotavirus
        • Pediatric (Children) Rotavirus
        • Adult Rotavirus
      • Herpes Zoster
        • Pediatric (Children) Herpes Zoster
        • Adult Herpes Zoster
      • Japanese Encephalitis
        • Pediatric (Children) Japanese Encephalitis
        • Adult Japanese Encephalitis
      • RSV
        • Pediatric (Children) RSV
        • Adult RSV
      • Others Viral Vaccines
        • Pediatric (Children) Others Viral Vaccines
        • Adult Others Viral Vaccines
    • Bacterial Vaccines
      • Meningococcal Diseases
        • Pediatric (Children) Meningococcal Diseases
        • Adult Meningococcal Diseases
      • Pneumococcal diseases
        • Pediatric (Children) Pneumococcal diseases
        • Adult Pneumococcal diseases
      • DPT
        • Pediatric (Children) DPT
        • Adult DPT
      • Others Bacterial Vaccines
        • Pediatric (Children) Others Bacterial Vaccines
        • Adult Others Bacterial Vaccines
    • Cancer Vaccines
      • Pediatric (Children) Cancer Vaccines
      • Adult Cancer Vaccines
    • Allergy Vaccines
      • Pediatric (Children) Allergy Vaccines
      • Adult Allergy Vaccines
    • Other Indication
      • Pediatric (Children) Other Indication
      • Adult Other Indication
  • Global Vaccine Type Outlook (Revenue, USD Million, 2021-2033)
    • Subunit Vaccines
      • Recombinant Vaccines
      • Conjugate Vaccines
      • Toxoid Vaccines
    • Inactivated
    • Live Attenuated
    • mRNA Vaccines
    • Viral Vector Vaccines
  • Global Vaccine Route of Administration Outlook (Revenue, USD Million, 2021-2033)
    • Oral
    • Parenteral
    • Nasal
  • Global Vaccine Age Group Outlook (Revenue, USD Million, 2021-2033)
    • Pediatric Age Group
    • Adult Age Group
  • Global Vaccine Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
    • Hospital & Retail Pharmacies
    • Government Suppliers
    • Others Distribution Channel

Reasons to subscribe to Global vaccine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global vaccine market databook

  • Our clientele includes a mix of vaccine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global vaccine market , including forecasts for subscribers. This global databook contains high-level insights into Global vaccine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global vaccine market size, by regions, 2021-2033 (US$M)

Top 10 countries: Vaccine market size, 2024 (US$M)

Global vaccine market share, by type, 2024 & 2030 (%, US$M)

Vaccine market: Opportunity assessment by country

Global vaccine market, by region, 2025 (US$M)

Global vaccine market size, by regions, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online